GSK961081
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Over the last decade, there has been a steady increase in the use of fixed dose combinations for the treatment of a range of…
To investigate the pharmacokinetics of inhaled batefenterol (BAT) and fluticasone furoate (FF) given alone or in combination via…
To investigate the pharmacokinetics and pharmacodynamics of inhaled GSK961081 and fluticasone propionate (FP) given alone…
GSK961081 is a bifunctional molecule demonstrating both muscarinic antagonist and &bgr;-agonist activities. This was a 4-week…
The aim of this study was to characterise population pharmacokinetics (PK) and pharmacodynamics (PD) of GSK961081 (MABA), a bi…
Introduction GSK961081 is a dual pharmacophore demonstrating both muscarinic antagonist and beta agonist activities in one…
Introduction: GSK961081 is a dual pharmacophore with both muscarinic antagonist and beta 2 agonist (MABA) activity. Objective: To…